Ticker
RNAZCompany Name
TRANSCODE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Total Debt | Debt to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 8.27M | $ 0 | 0% |
3/31/2025 | $ 13.19M | $ 0 | 0% |
12/31/2024 | $ 7.29M | $ 38.29K | 0.52% |
9/30/2024 | $ 3.94M | $ 152.48K | 3.87% |
6/30/2024 | $ 4.82M | $ 227.25K | 4.71% |
3/31/2024 | $ 7.29M | $ 339.41K | 4.66% |
12/31/2023 | $ 5.17M | $ 450.57K | 8.72% |
9/30/2023 | $ 10.23M | $ 594.69K | 5.81% |
6/30/2023 | $ 5.88M | $ 663.29K | 11.28% |
3/31/2023 | $ 5.59M | $ 768.23K | 13.74% |
Debt / Assets
(=) Debt to Assets
Debt to Assets for TRANSCODE THERAPEUTICS INC is calculated as follows: Debt [ $ 2.09M ] / Assets [ $ 1.06M ]
(=) Debt to Assets [ 197.72% ]
Minimum
Sep 30, 2021
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 4.37K |
---|---|
min | 0% |
max | 116.6% |
average | 26.33% |
median | 21.09% |
std | 24.49% |